(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...

Bausch + Lomb’s second quarter revealed a mixed response from the market, as revenue growth outpaced analyst expectations but ...